Pharmaceutical Hot Melt Extrusion Equipment Market

Pharmaceutical Hot Melt Extrusion Equipment Market  was valued at US $ 34.80 Mn. in 2023, and it is expected to reach US $ 45.64 Mn. by 2030 with a CAGR of 3.95% during the forecast period.

Pharmaceutical Hot Melt Extrusion Equipment Market Overview:

Hot-melt extrusion (HME) is a continuous process that involves applying pressure and heat to melt a polymer and forcing it through an aperture. In the rubber, plastic, and food industries, it is a widely used processing method. More than half of all plastic products, including sheets, tubes, bags, films, fibers, foams, and pipes, are made by hot-melt extrusion.

The use of heat, agitation, and pressure through the extrusion channel to mix components and force them into the desired form is known as hot-melt extrusion. The hot-melt extrusion technique is used to improve the bioavailability of beneficial pharmaceutical compounds.To know about the Research Methodology :- Request Free Sample Report

Pharmaceutical Hot Melt Extrusion Equipment Market Dynamics:

Ability to develop innovative medicines with higher bioavailability.

Thanks to the potential of the equipment to develop innovative medications with higher bioavailability, the usage of hot-melt extrusion technology in pharmaceutical applications are continuously growing. The implementation of the HME technique in drug-delivery systems, particularly in solid dosage forms and transdermal patches has been driven by the development of innovative medications with challenging solubility and bioavailability. The rise in demand for hot melt extrusion in pharmaceutical applications are being driven by an increase in the number of innovative medications with low bioavailability and the need to get them on the market.

The high cost of installation and maintenance of this equipment are expected to hamper the growth of the market over the forecast period.

Market Segment Analysis:

Based on Type, the global market is segmented into three types as follows, RAM extruders, Radial screen equipment, Roll and screw extruders (single-screw, twin-screw, and multi-screw). In 2023, the twin-screw extruders (TSE) segment was dominant and held xx% of the overall market share. This segment is anticipated to grow at a CAGR of xx% during the forecast period as TSEs are the most extensively used equipment for developing solid dosage forms, which uses both distributive and dispersive mixing. Every major pharmaceutical company has used TSE in pharmaceutical manufacturing as a result of the FDA's (Food and Drug Administration) process analytical technology effort (PAT).

TSE technology has been used to formulate novel doses as part of the process analytical technology program. More work is being done on developing TSE equipment for testing early-stage compounds that are only available in small quantities.

Market Regional Insights:

In 2023, North America was dominant among all the regions and its market was valued at the US $7.56 million. The presence of a large number of pharmaceutical companies that have implemented HME systems in drug production, and the widespread use of HME in CGMP (Current Good Manufacturing Practice) regulations, is expected to ensure North America's dominance on the global platform.

During the forecast period, demand for HME equipment in the European pharmaceutical industry is likely to grow at a stable CAGR of 2.8%. The European market is primarily driven by a high demand for novel medication production methods.

In Asia Pacific, China, the world's second-largest economy, is expected to reach a the market size of US $7800 million by 2030, with a CAGR of approximately 6.2%, as well as Japan and Canada are expected to grow at a CAGR of approximately 2.3% and 3.1% respectively.

The objective of the report is to present a comprehensive analysis of the global market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the global market dynamics, structure by analyzing the market segments and project the global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global market makes the report investor's guide.

Pharmaceutical Hot Melt Extrusion Equipment Market Scope: Inquire before buying

Pharmaceutical Hot Melt Extrusion Equipment Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Pharmaceutical Hot Melt Extrusion Equipment Market Key Players

1. Baker Perkins Ltd.
2. Coperion GmbH
3. Gabler GmbH & Co. KG
4. Milacron Holdings Corp.
5. Leistritz Advanced Technologies Corp.
6. Thermo Fisher Scientific, Inc.
7. Xtrutech Ltd.
8. Catalent’s OptiMelt
9. AbbVie
10. Foster
11. Midas Pharma
12. PMC Isochem
13. Pensatech Pharma GmbH
14. PozLab
15. Green Ridge Consulting
16. PriviLS LLP
17. Others

Frequently Asked Questions:

1. What is the forecast period considered for the Pharmaceutical Hot Melt Extrusion Equipment market report?

Ans. The considered forecast period for the pharmaceutical hot melt extrusion equipment market is 2024-2030.

2. Which key factors are hindering the growth of the Pharmaceutical Hot Melt Extrusion Equipment market?

Ans. The high cost of procuring, installation, and maintenance are the key factors expected to hinder the growth of the market during the forecast period.

3. What is the compound annual growth rate (CAGR) of the Pharmaceutical Hot Melt Extrusion Equipment market for the next 6 years?

Ans. The global pharmaceutical hot melt extrusion equipment market is expected to grow at a CAGR of 3.95% during the forecast period.

4. What are the key factors driving the growth of the Pharmaceutical Hot Melt Extrusion Equipment market?

Ans. The ability to develop innovative medicines with higher bioavailability is the factor expected to drive the growth of the market during the forecast period.

5. Which are the worldwide major key players covered for the Pharmaceutical Hot Melt Extrusion Equipment market report?

Ans. Baker Perkins Ltd., Coperion GmbH, Gabler GmbH & Co. KG, Milacron Holdings Corp., Leistritz Advanced Technologies Corp., Thermo Fisher Scientific Inc., Xtrutech Ltd., Catalent’s OptiMelt, AbbVie, Foster, Midas Pharma, PMC Isochem, Pensatech Pharma GmbH, PozLab, Green Ridge Consulting, PriviLS LLP, and Others.